目的 探讨肺组织中 II 型 11β- 羟基类固醇脱氢酶（11β-HSD2）及相关信号分子在新生大鼠持续性肺动脉高压（PPH）发病中的作用。方法 6只Sprague-Dawley大鼠在孕第19天随机分为PPH组和对照组，每组 3 只，其中 PPH 组置于 12% 的氧浓度中及腹腔内注射吲哚美辛 0.5 mg/kg，每日两次，连续 3 d，建立胎鼠肺动脉高压模型；对照组暴露在空气中并同时腹腔注射等量生理盐水。对照组和 PPH 组于孕第 22 天剖腹分别获取新生大鼠 28 只、31 只，两组分别随机处死 15 只新生大鼠。采用激光共聚焦技术观察 11β-HSD2 在新生大鼠肺组织中的表达，ELISA 检测 PPH 大鼠血清中皮质醇及肺组织中前列环素、肾素、血管紧张素、醛固酮的浓度。结果 11β-HSD2 在对照组及 PPH 组大鼠肺组织广泛表达。与对照组比较，PPH 组肺组织中 11β-HSD2 及前列环素的表达降低（P<0.05），而血清皮质醇及肺组织中肾素、血管紧张素、醛固酮的表达增高（P<0.05）。结论 11β-HSD2 及相关信号分子在新生大鼠 PPH 的发生发展中发挥了作用。
Abstract
Objective To study the roles of type II 11β-hydroxysteroid dehydrogenase（11β-HSD2) and it's signaling factors in the lung tissue in pathogenesis of persistent pulmonary hypertension（PPH) in neonatal rats.Methods Six Sprague-Dawley rats on the 19th day of pregnancy were randomly divided into PPH and control groups（n=3 each). The PPH group was intraperitoneally injected with indomethacin（0.5 mg/kg) twice daily and exposed in 12% oxygen for three days, in order to prepare a fetal rat model of PPH. The control group was intraperitoneally injected with an equal volume of normal saline and exposed to air. Neonatal rats were born by caesarean section from both groups on the 22nd day of pregnancy. In each group, 15 neonatal rats were randomly selected and sacrificed. 11β-HSD2 expression in the lung tissue of neonatal rats were observed by Confocal laser technology, and serum cortisol levels and prostacyclin, renin, angiotensin and aldosterone in the lung tissue of both groups were measured using ELISA. Results 11β-HSD2 protein was widely expressed in the lung tissue of the control and PPH groups. The levels of 11β-HSD2 and prostacyclin in the lung tissue were lower in the PPH group than in the control group, while serum cortisol levels and renin, angiotensin and aldosterone in the lung tissue were higher in the PPH group than in the control group（P<0.05).Conclusion 11β-HSD2 and it's signaling factors play roles in pathogenesis of PPH in neonatal rats.
关键词
持续性肺动脉高压 /
II 型 11β- 羟基类固醇脱氢酶 /
皮质醇 /
血管紧张素 /
醛固酮 /
新生大鼠
Key words
Persistent pulmonary hypertension /
Type II 11β-hydroxysteroid dehydrogenase /
Cortisol /
Angiotensin /
Aldosterone /
Neonatal rats
{{custom_sec.title}}
{{custom_sec.title}}
{{custom_sec.content}}
参考文献
[1] 杜立中, 魏克伦, 孙眉月.新生儿持续肺动脉高压诊疗常规[J].中华儿科杂志, 2002, 40(7): 438-439.
[2] Xu XF, Gu WZ, Wu XL, et al.Fetal pulmonary vascular remodeling in a rat model induced by hypoxia and indomethacin[J].J Matern Fetal Neonatal Med, 2011, 24(1):172-182.
[3] Das R, Balonan L, Ballard HJ, et al.Chronic hypoxia inhibits the antihypertensive effect of melatonin on pulmonary artery[J].Int J Cardiol, 2008, 126(3): 340-345.
[4] 桑葵, 周英, 李明霞.缺氧性肺动脉高压新生大鼠肺血管重塑的研究 [J].中国当代儿科杂志, 2012, 14(3): 210-214.
[5] 姚锋祥, 汤彪, 黄引平.胎盘 11β-HSD2 表达与皮质醇代谢水平的关系及其对子痫前期的相关性研究[J].中国妇幼保健,2013, 28(8): 1336-1339.
[6] Dy J, Guan H, Sampath-Kumar R, et al.Placental 11beta-hydroxysteroid dehydrogenase type 2 is reduced in pregnancies complicated with idiopathic intrauterine growth restriction:evidence that this is associated with an attenuated ratio of cortisone to cortisol in the umbilical artery[J].Placenta, 2008,29(2): 193-200.
[7] Ostreicher I, Almeida JR, Campean V, et al.Changes in 11beta-hydroxysteroid dehydrogenase type 2 expression in a low-protein rat model of intrauterine growth restriction[J].Nephrol Dial Transplant, 2010, 25(10): 3195-3203.
[8] Garbrecht MR, Schmidt TJ, Krozowski ZS, et al.11Beta-hydroxysteroid dehydrogenase type 2 and the regulation of surfactant protein A by dexamethasone metabolites[J].Am J Physiol Endocrinol Metab, 2006, 290(4): E653-E660.
[9] 陈晓琳.11β- 羟基类固醇脱氢酶 2 与炎性疾病的关系 [J].医学综述, 2011, 17(12): 1769-1772.
[10] Campino C, Carvajal CA, Cornejo J, et al.11β-hydroxysteroid dehydrogenase type-2 and type-1（11β-HSD2 and 11β-HSD1) and 5β-reductase activities in the pathogenia of essential hypertension[J].Endocrine, 2010, 37(1): 106-114.
[11] Ong SLH, Whitworth JA.How do glucocorticoids cause hypertension: role of nitric oxide deficiency, oxidative stress,and eicosanoids[J].Endocrinol Metab Clin North Am, 2011,40(2): 393-407.
[12] Dodt C, Wellhoner JP, Schutt M, et al.Glucocorticoids and hypertension[J].Internist（Berl), 2009, 50(1): 36-41.
[13] Hadoke PWF, Christy C, Kotelevtsev YV, et al.Endothelial cell dysfunction in mice after transgenic knockout of type 2, but not type 1, 11β-hydroxysteroid dehydrogenase[J].Circulation, 2001,104(23): 2832-2837.
[14] Hache M, Denault AY, Belisle S, et al.Inhaled prostacyclin（PGI2) is an effective addition to the treatment of pulmonary hypertension and hypoxia in the operating room and intensive care unit[J].Can J Anesth, 2001, 48(9): 924-929.
[15] Schütte H, Schell A, Schäfer C, et al.Subthreshold doses of nebulized prostacyclin and rolipram synergistaically protect against lung ischemia-reperfusion[J].Transplantation, 2003,75(6): 814-821.
[16] Tissot C, Beghetti M.Review of inhaled iloprost for the control of pulmonary artery hypertension in children[J].Vasc Health Risk Manag, 2009, 5(1): 325-331.
[17] 赵芳萍, 石静云, 易彬.新生儿持续肺动脉高压的治疗进展[J].中国妇幼保健, 2012, 27(22): 3521-3524.
[18] 张凌云, 高宝安.肺动脉平滑肌细胞与低氧性肺血管重塑形成机制 [J].中国动脉硬化杂志, 2013, 21（2): 177-181.
基金
国家自然基金资助项目（编号：81241123)。
PDF(2798 KB)
